SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — George H. W. Bush — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeorge H. W. Bush
Date of birth1924-06-12
IdentifiersMRN HR-ML018-SYN-TD; SSN (made up) 000-18-7245
Document date1991-05-20
AuthorDouglas Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review on methimazole for Graves' disease and atrial fibrillation. [S]

History of Present Illness

Mr. Bush returns twelve days after starting methimazole 20 mg daily, on metoprolol succinate 50 mg daily and apixaban 5 mg twice daily since his hospital stay. He has had no palpitations or irregular pulse on his home monitor and feels well. He has walked daily but has not run yet, as advised. He has had no fever, sore throat, mouth ulcers, rash, itching, yellow eyes, or dark urine on methimazole, and no bleeding or bruising on apixaban. He takes every dose. He has no eye pain, grittiness, or double vision. He saw the endocrinologist this morning, and radioactive iodine is planned for next week. [S]

ElementDetail
RhythmNo palpitations; regular pulse on home checks
Thyrotoxic symptomsFeels well; still a little heat-intolerant
Methimazole safetyNo fever, sore throat, rash, jaundice, or dark urine
Apixaban safetyNo bleeding or bruising; no missed doses
ActivityDaily walks; not yet running

Review of Systems

SystemResultFinding
CardiovascularNegativeNo palpitations, chest pain, lightheadedness, or ankle swelling
ConstitutionalPositiveStill a little heat-intolerant; no fever
EyesNegativeNo grittiness, pain, redness, or double vision
HematologicNegativeNo bleeding or bruising

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metoprolol succinate extended-release 50 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet each morningOral route1991-05-05 to 1991-07-17stoppedS
Apixaban 5 mg oral tablet, one tablet by mouth twice daily (started in hospital)One tablet twice dailyOral route1991-05-05 to 1991-09-11stoppedS
Methimazole 10 mg oral tablet, two tablets (20 mg) by mouth dailyTwo tablets once daily; stop three days before radioactive iodineOral route1991-05-08 to 1991-05-26completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1991-05-20Body height188cmS
1991-05-20Body weight86.4kgS
1991-05-20Body mass index (BMI) [Ratio]24.4kg/m2S
1991-05-20Systolic blood pressure132mm[Hg]S
1991-05-20Diastolic blood pressure70mm[Hg]S
1991-05-20Heart rate72/minS
1991-05-20Respiratory rate14/minS
1991-05-20Body temperature36.9CelS
1991-05-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1991-05-20Thyrotropin [Units/volume] in Serum or Plasma0.01m[IU]/L0.4-4 mIU/LLowS
1991-05-20Thyroxine (T4) free [Mass/volume] in Serum or Plasma2.2ng/dL0.8-1.8 ng/dLHighS
1991-05-20Triiodothyronine (T3) [Mass/volume] in Serum or Plasma176ng/dL80-200 ng/dLNormalS
1991-05-20Neutrophils [#/volume] in Blood by Automated count3.510*3/uL1.5-7.5 10*3/uLNormalS
1991-05-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-55 U/LNormalS

Physical Exam

Vital signs recorded on 1991-05-20; see the Vital Signs section. [S]

SystemFinding
GeneralWell; calmer than at intake
EyesNo lid retraction, lid lag, proptosis, or redness; eye movements full
NeckDiffusely enlarged, non-tender thyroid without nodules
CardiovascularRegular rhythm at 72 per minute; no murmur
NeurologicalFine tremor of the outstretched hands, less than at intake

Problems

ProblemClinical statusVerificationCodeProvenance
Paroxysmal atrial fibrillation, first detected four days before intake while running, triggered by hyperthyroidism; CHA2DS2-VASc 1; synthetic modern episode linked to his documented atrial fibrillationactiveconfirmed I48.0S — Synthetic modern classification of a documented arrhythmia.
Graves' disease with hyperthyroidism; synthetic modern diagnosis linked to his documented Graves' diseaseactiveconfirmed E05.00S — Synthetic modern diagnosis confirmed by thyroid tests and TSH receptor antibody; the historical diagnosis is D.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationHeart rate and rhythmEvery visitCompleted today72 per minute, regular; no recurrence of atrial fibrillation since discharge
ExaminationBlood pressureEvery visit; target below 130/80Completed today132/70 mmHg
ExaminationWeight and BMIEvery visitCompleted today86.4 kg, BMI 24.4
SurveyAtrial fibrillation symptomsEvery visitCompleted todayNone
Imaging12-lead ECG or rhythm stripWhen rhythm assessment is indicated or symptoms changeNot indicatedPulse regular on examination and on home checks; intake ECG in sinus rhythm
ImagingTransthoracic echocardiogramAt diagnosis; repeat with clinical changeUp to dateNormal structure, left atrial size, and ejection fraction in hospital
SurveyCHA2DS2-VASc and HAS-BLEDYearly and with any change in clinical statusUp to dateScored at intake: CHA2DS2-VASc 1 (age 65 to 74), HAS-BLED 1 (age over 65)
Medication safetyAnticoagulant adherence and bleedingEvery visitCompleted todayNo missed doses; no bleeding
LaboratoryCreatinine and eGFR on apixabanAt baseline and at least yearlyUp to dateCreatinine 0.92 mg/dL, eGFR 87 at intake; full dose is correct
LaboratoryHemoglobin on anticoagulationAt least yearly; sooner with symptomsUp to date14.8 g/dL at intake
Self-managementAlcohol, tobacco, and physical activityEvery visitCompleted todayNo alcohol since the hospital stay; never used tobacco; daily walks, running to resume in steps
SurveySleep apnea symptom screenAt diagnosis and at least yearlyDeferredNot asked at intake or today. Deviation: the screen due at diagnosis was missed; it is added to the next visit's checklist
LaboratoryFree T4 and total T3 on methimazoleTwo to six weeks after starting, then every four to eight weeksCompleted todayFree T4 2.2 ng/dL, total T3 176 ng/dL, TSH 0.01 mIU/L
LaboratoryWhite cell count with differential and liver tests on methimazoleAt baseline; then with fever, sore throat, jaundice, or other symptomsCompleted todayChecked before radioactive iodine at the consultant's request: neutrophils 3.5 x10³/µL, ALT 30 U/L
Medication safetyMethimazole side effectsEvery visit while on methimazoleCompleted todayNone; written warning about fever and sore throat repeated
ExaminationEye assessment for Graves' orbitopathyAt diagnosis and before radioactive iodineCompleted todayNo orbitopathy; never smoker, so no steroid cover is needed
ReferralEndocrinology consultationAt diagnosis of Graves' disease, to choose definitive treatmentCompleted todaySeen today; radioactive iodine chosen

Goal progress:

Guideline basis: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (2023); 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016); CMID: Clinical Monitoring Intelligence Database, atrial fibrillation and hypothyroidism monographs (2026)

Follow-up: Radioactive iodine next week. Review with thyroid tests in about seven weeks, or sooner for palpitations, fever, or sore throat. Next scheduled visit 1991-07-17: seven-week review after radioactive iodine. [S]